Klivira
Request demo

Optimizing Infectious Disease Availity Integration for Prior Authorization

Klivira’s infectious disease Availity integration optimizes prior authorization workflows, ensuring timely access to critical therapies while reducing administrative burden.

For infectious disease clinics and health systems, managing prior authorizations for high-cost antivirals, antifungals, and OPAT regimens presents significant operational challenges. Manual Availity portal submissions divert valuable staff time, delay patient care, and introduce errors. Klivira addresses these bottlenecks by automating the PA process directly through Availity.

The Unique Prior Authorization Landscape in Infectious Disease

Infectious disease (ID) practices frequently manage complex patient cohorts requiring specialized, high-cost therapies such as advanced antivirals for HIV and HCV, specialty antifungals for invasive infections, and outpatient parenteral antibiotic therapy (OPAT). These treatments are often critical for managing disease progression and preventing complications, making efficient prior authorization (PA) essential. The volume and complexity of documentation for these specific PAs can strain revenue cycle and PA teams.

Leveraging Availity for Infectious Disease Payer Submissions

Availity, a prominent multi-payer clearinghouse and portal, serves as a critical gateway for submitting prior authorizations to most major commercial payers. For ID clinics, efficient interaction with Availity Essentials is non-negotiable for securing approvals for high-cost medications and services. Automating this interaction reduces manual data entry and improves the consistency and timeliness of submissions.

Common Prior Authorization Triggers in ID Workflows

  • High-cost antiviral therapies (e.g., for HCV, HIV, CMV)
  • Specialty antifungals (e.g., for invasive fungal infections)
  • Outpatient Parenteral Antibiotic Therapy (OPAT) initiation and extension
  • Specific advanced diagnostic imaging (e.g., PET scans for infection localization)
  • Immunomodulators or biologics used in certain ID-related conditions

Streamlining EMR-to-Availity Prior Authorization Workflows

Infectious disease clinicians typically order therapies and diagnostics within their EMR systems (e.g., Epic, Cerner). The challenge lies in seamlessly transferring relevant clinical data, including ePHI from order sets, lab results, and progress notes, to Availity's ePA submission channels, whether via X12 278 transactions or proprietary web portals. Klivira’s integration focuses on automating this data extraction and mapping, ensuring that payer-specific clinical criteria are met without extensive manual effort.

Evidence-Based Prior Authorization for ID Therapies

Prior authorizations for infectious disease therapies are heavily informed by specific clinical guidelines. Organizations such as the Infectious Diseases Society of America (IDSA), the American Academy of HIV Medicine (AAHIVM), and sometimes NCCN for related conditions, provide criteria that payers often adopt. Klivira's platform helps align submitted documentation with these evidence-based guidelines, facilitating smoother approvals for complex ID cases and reducing administrative burden associated with appeals.

Klivira's Impact on Infectious Disease Availity Integration

Klivira automates the prior authorization process by integrating directly with your EMR and Availity. For infectious disease practices, this means automated extraction of necessary clinical data for antivirals, antifungals, and OPAT, accurate population of Availity's ePA forms, and efficient submission and tracking. Our solution reduces manual data entry, accelerates turnaround times, and helps mitigate denials, ensuring patients receive timely access to critical infectious disease treatments.

Frequently asked questions

How does Klivira handle specific clinical documentation requirements for ID PAs submitted via Availity?

Klivira leverages SMART on FHIR and other EMR integration methods to extract relevant clinical data, such as lab results (viral loads, CD4 counts), culture sensitivities, and physician notes. This structured data is then mapped to Availity's ePA submission fields, ensuring all required clinical evidence, aligned with payer-specific medical policies and guidelines (e.g., IDSA), is included for high-cost antivirals or OPAT.

Can Klivira manage prior authorizations for all types of infectious disease drugs through Availity?

Klivira's Availity integration supports a broad spectrum of infectious disease prior authorizations, including high-cost antivirals (e.g., for HIV, HCV), antifungals, and OPAT. The platform is designed to handle the diverse documentation requirements for these complex therapies, ensuring comprehensive submissions to commercial payers utilizing Availity.

What is the typical turnaround time improvement for ID PAs using Klivira's Availity integration?

While specific turnaround times vary by payer and case complexity, Klivira significantly reduces the manual effort and delays associated with infectious disease prior authorizations. By automating data extraction, form submission, and status tracking through Availity, our clients typically experience faster submission cycles and reduced administrative lead times, accelerating patient access to critical therapies.

How does Klivira ensure compliance with HIPAA when integrating EMR data with Availity for ID PAs?

Klivira is built with robust security and privacy controls, adhering to HIPAA regulations for ePHI handling. Our integration with EMRs and Availity utilizes secure, encrypted channels and strict access protocols. We only process the minimum necessary data required for prior authorization, ensuring patient confidentiality throughout the infectious disease PA workflow.

Does Klivira support both X12 278 and proprietary Availity portal submissions for ID PAs?

Yes, Klivira's integration strategy is designed to accommodate various payer channels within Availity. This includes leveraging the X12 278 transaction set where supported by the payer, as well as automating submissions through proprietary web portals within Availity Essentials for payers that require it. This ensures comprehensive coverage for infectious disease prior authorizations.

Related coverage

Other infectious-disease prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo